|  | PK/PD Laboratory -  Hands-on PK evaluation | 
| "PK/PD 
        Laboratory - Hands-on PK evaluation"  Enjoy our offer to "BRING 
        YOUR OWN DATA" 
 You 
        may submit your data via email to bulitta@ibmp.osn.de 
        . Please indicate in the email text, when you would like to discuss the 
        analysis of your data at the PK/PD Laboratory. For sophisticated PK/PD 
        analyses you may also discuss strategies with the experts. Thus, we could 
        reserve time slots for you. We would very much appreciate submission at 
        your earliest convenience. Submissions will be reserved on a "first 
        come first served basis". Please note, Pharsight offers a Pharsight Academic Licensing (PAL) program for academic, research, and educational use of Pharsight products at selected Academic Institutions. This program allows academic institutions the use of Pharsight software products free of charge. License conditions can be found under this link. 
 The 
        following Pharsight software products will be presented by senior experts 
        at the PK/PD Laboratory: | 
| WinNonlin is a PK/PD software that provides a complete solution with analysis, statistics, modeling, and visualization tools included in one package. Its intuitive interface and flexible framework facilitate the use of this powerful application. WinNonlin is a software that can be applied for high-throughput pharmacokinetic analysis. However, any kind of linear and nonlinear regression can be performed with WinNonlin. It is no way limited to first order differential equation systems. Its Table generator and Graph Wizard as in-built features allow extremely fast overviews even for large datasets. After 
        PK/PD evaluation, statistical analyses (including average and individual 
        bioequivalence, ANOVA and ANCOVA) can be performed by non-professional 
        statisticians. It may take only minutes from starting with concentration 
        time raw data to the final statistical analysis (even for beginners). | 
| Conducting 
        population PK/PD analysis is particularly important in later phases of 
        clinical trials. Population PK/PD modeling can directly include subject 
        specific factors like sex, ethnic group, age, renal function, weight, 
        etc. in the analysis. This allows subgroup analysis and provides a basis 
        for understanding any differences that may exist. | 
| Before 
        starting each actual clinical trial, the Pharsight Trial Simulator provides 
         In 
        the late Phase 2 and Phase 3 trials, use of the Pharsight Trial Simulator 
        may eliminate costly missteps and accelerates progress along the path 
        to approval and marketing.  |